Literature DB >> 25030422

The TGF-β-inducible miR-23a cluster attenuates IFN-γ levels and antigen-specific cytotoxicity in human CD8⁺ T cells.

P Anoop Chandran1, Andreas Keller2, Lasse Weinmann3, Ahmed Adel Seida4, Matthias Braun5, Katerina Andreev6, Birgitt Fischer7, Evi Horn7, Stefanie Schwinn5, Markus Junker4, Roland Houben8, Yvonne Dombrowski4, Johannes Dietl7, Susetta Finotto6, Matthias Wölfl5, Gunter Meister9, Jörg Wischhusen10.   

Abstract

Cytokine secretion and degranulation represent key components of CD8(+) T-cell cytotoxicity. While transcriptional blockade of IFN-γ and inhibition of degranulation by TGF-β are well established, we wondered whether TGF-β could also induce immune-regulatory miRNAs in human CD8(+) T cells. We used miRNA microarrays and high-throughput sequencing in combination with qRT-PCR and found that TGF-β promotes expression of the miR-23a cluster in human CD8(+) T cells. Likewise, TGF-β up-regulated expression of the cluster in CD8(+) T cells from wild-type mice, but not in cells from mice with tissue-specific expression of a dominant-negative TGF-β type II receptor. Reporter gene assays including site mutations confirmed that miR-23a specifically targets the 3'UTR of CD107a/LAMP1 mRNA, whereas the further miRNAs expressed in this cluster-namely, miR-27a and -24-target the 3'UTR of IFN-γ mRNA. Upon modulation of the miR-23a cluster by the respective miRNA antagomirs and mimics, we observed significant changes in IFN-γ expression, but only slight effects on CD107a/LAMP1 expression. Still, overexpression of the cluster attenuated the cytotoxic activity of antigen-specific CD8(+) T cells. These functional data thus reveal that the miR-23a cluster not only is induced by TGF-β, but also exerts a suppressive effect on CD8(+) T-cell effector functions, even in the absence of TGF-β signaling.
© 2014 Society for Leukocyte Biology.

Entities:  

Keywords:  antigen-specific T cells; miRNA induction; tolerance; tumor targets

Mesh:

Substances:

Year:  2014        PMID: 25030422     DOI: 10.1189/jlb.3A0114-025R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  16 in total

1.  Reduced Expression of miR-23a Suppresses A20 in TLR-stimulated Macrophages.

Authors:  Ping Peng; Zhiyi Li; Xinyan Liu
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

2.  Excessive expression of miR-27 impairs Treg-mediated immunological tolerance.

Authors:  Leilani O Cruz; Somaye Sadat Hashemifar; Cheng-Jang Wu; Sunglim Cho; Duc T Nguyen; Ling-Li Lin; Aly Azeem Khan; Li-Fan Lu
Journal:  J Clin Invest       Date:  2017-01-09       Impact factor: 14.808

Review 3.  Non-Coding RNAs as Regulators and Markers for Targeting of Breast Cancer and Cancer Stem Cells.

Authors:  Kirti S Prabhu; Afsheen Raza; Thasni Karedath; Syed Shadab Raza; Hamna Fathima; Eiman I Ahmed; Shilpa Kuttikrishnan; Lubna Therachiyil; Michal Kulinski; Said Dermime; Kulsoom Junejo; Martin Steinhoff; Shahab Uddin
Journal:  Cancers (Basel)       Date:  2020-02-04       Impact factor: 6.639

4.  TGF-β blockade depletes T regulatory cells from metastatic pancreatic tumors in a vaccine dependent manner.

Authors:  Kevin C Soares; Agnieszka A Rucki; Victoria Kim; Kelly Foley; Sara Solt; Christopher L Wolfgang; Elizabeth M Jaffee; Lei Zheng
Journal:  Oncotarget       Date:  2015-12-15

5.  MicroRNAs for Fine-Tuning of Mouse Embryonic Stem Cell Fate Decision through Regulation of TGF-β Signaling.

Authors:  Christiana Hadjimichael; Christoforos Nikolaou; Joseph Papamatheakis; Androniki Kretsovali
Journal:  Stem Cell Reports       Date:  2016-02-11       Impact factor: 7.765

6.  Circulating Plasma microRNAs can differentiate Human Sepsis and Systemic Inflammatory Response Syndrome (SIRS).

Authors:  Stefano Caserta; Florian Kern; Jonathan Cohen; Stephen Drage; Sarah F Newbury; Martin J Llewelyn
Journal:  Sci Rep       Date:  2016-06-20       Impact factor: 4.379

7.  MicroRNA-491 regulates the proliferation and apoptosis of CD8(+) T cells.

Authors:  Ting Yu; Qian-Fei Zuo; Li Gong; Li-Na Wang; Quan-Ming Zou; Bin Xiao
Journal:  Sci Rep       Date:  2016-08-03       Impact factor: 4.379

8.  miR-23a, miR-146a and miR-301a confer predisposition to Vogt-Koyanagi-Harada syndrome but not to Behcet's disease.

Authors:  Shengping Hou; Zi Ye; Dan Liao; Lin Bai; Yunjia Liu; Jun Zhang; Aize Kijlstra; Peizeng Yang
Journal:  Sci Rep       Date:  2016-01-28       Impact factor: 4.379

9.  Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF-β and miR23a transfer.

Authors:  Guy Berchem; Muhammad Zaeem Noman; Manon Bosseler; Jerome Paggetti; Sonia Baconnais; Eric Le Cam; Arash Nanbakhsh; Etienne Moussay; Fathia Mami-Chouaib; Bassam Janji; Salem Chouaib
Journal:  Oncoimmunology       Date:  2015-06-24       Impact factor: 8.110

10.  miR-23∼27∼24 clusters control effector T cell differentiation and function.

Authors:  Sunglim Cho; Cheng-Jang Wu; Tomoharu Yasuda; Leilani O Cruz; Aly Azeem Khan; Ling-Li Lin; Duc T Nguyen; Marina Miller; Hyang-Mi Lee; Ming-Ling Kuo; David H Broide; Klaus Rajewsky; Alexander Y Rudensky; Li-Fan Lu
Journal:  J Exp Med       Date:  2016-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.